Literature DB >> 2881134

Serum reactivity to human T-cell leukaemia/lymphoma virus type I proteins in patients with large granular lymphocytic leukaemia.

G Starkebaum, T P Loughran, V S Kalyanaraman, M E Kadin, P G Kidd, J W Singer, F W Ruscetti.   

Abstract

To investigate the possibility that the recently recognised syndrome, leukaemia of large granular lymphocytes, could be associated with human T-cell leukaemia/lymphoma virus type I (HTLV-I), sera from 12 patients with this type of leukaemia were tested by the use of western-blot techniques for IgG antibodies to proteins related to human T-cell leukaemia/lymphoma virus type I (HTLV-I). Sera from 6 patients, including 2 patients with rheumatoid arthritis, reacted with p19 or p24 retroviral proteins or both. In contrast, no sample from 32 patients with uncomplicated rheumatoid arthritis, 27 with Felty's syndrome, 11 with other connective tissue disorders, or 21 normal individuals reacted with HTLV-I. The results suggest that leukaemia of large granular lymphocytes may be associated with a retrovirus related to HTLV-I.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2881134     DOI: 10.1016/s0140-6736(87)90236-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  19 in total

1.  Large granular lymphocytosis associated with rheumatoid arthritis.

Authors:  A Samanta; I Grant; F E Nichol; J H Pringle; J K Wood; A C Campbell
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

2.  Lymphoproliferative disease of granular lymphocytes in a patient with concomitant hepatitis B virus infection of CD4 lymphocytes.

Authors:  C Agostini; R Zambello; P Pontisso; A Alberti; L Trentin; F Siviero; R Foà; F Pandolfi; G Semenzato
Journal:  J Clin Immunol       Date:  1989-09       Impact factor: 8.317

3.  Absence of antibodies to HTLV-I/II in French patients with hematological malignancies.

Authors:  G Agius; V Vaillant; R J Biggar; A Brizard; S Ranger; G Dindinaud; M Castets
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

4.  Retroviral sero-reactivity in LGL leukaemia patients and family members.

Authors:  Susan B Nyland; David J Feith; Mary Poss; Thomas L Olson; Daniel J Krissinger; Bernard J Poiesz; Francis W Ruscetti; Thomas P Loughran
Journal:  Br J Haematol       Date:  2019-10-14       Impact factor: 6.998

5.  A case presenting with rapid renal damage caused by immunoglobulin D lambda-type multiple myeloma accompanied by granular lymphocyte proliferative disorder.

Authors:  Naro Ohashi; Kosuke Hirota; Akashi Togawa; Nobuharu Kosugi; Kunio Ohyama
Journal:  Clin Exp Nephrol       Date:  2011-03-03       Impact factor: 2.801

6.  Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia.

Authors:  Jun Yang; P K Epling-Burnette; Jeffrey S Painter; Jianxiang Zou; Fanqi Bai; Sheng Wei; Thomas P Loughran
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

7.  TCR1+ large granular lymphocyte proliferation in rheumatoid arthritis.

Authors:  J G Kuipers; R Jacobs; A Kemper; H Zeidler; R E Schmidt
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

Review 8.  Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia.

Authors:  HeeJin Cheon; Karolina H Dziewulska; Katharine B Moosic; Kristine C Olson; Alejandro A Gru; David J Feith; Thomas P Loughran
Journal:  Curr Hematol Malig Rep       Date:  2020-04       Impact factor: 3.952

9.  Pure red cell aplasia associated with malignant thymoma, myasthenia gravis, polyclonal large granular lymphocytosis and clonal thymic T cell expansion.

Authors:  S I Handa; K P Schofield; M Sivakumaran; M Short; R S Pumphrey
Journal:  J Clin Pathol       Date:  1994-07       Impact factor: 3.411

10.  Angiocentric lymphoma with granulomatous panniculitis in the skin expressing natural killer cell and large granular T-cell phenotypes.

Authors:  M Takeshita; N Kimura; J Suzumiya; K Ohshima; M Kikuchi; R Watanabe; T Okamura; H Goto
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.